Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Martin G McCabe"'
Autor:
Morven C Brown, Vera Araújo-Soares, Roderick Skinner, Jamie Brown, Adam W Glaser, Helena Hanratty, Martin G McCabe, Ana-Ecaterina Amariutei, Sabrina Mauri, Linda Sharp
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0299321 (2024)
BackgroundChildhood, adolescent and young adult (CAYA) cancer survivors are vulnerable to adverse late-effects. For CAYA cancer survivors, tobacco smoking is the most important preventable cause of ill-health and early death. Yet, effective strategie
Externí odkaz:
https://doaj.org/article/8e223d60800f4d01aef752ae5818b7f2
Autor:
Michaela-Kristina Keck, Martin Sill, Andrea Wittmann, Piyush Joshi, Damian Stichel, Pengbo Beck, Konstantin Okonechnikow, Philipp Sievers, Annika K. Wefers, Federico Roncaroli, Shivaram Avula, Martin G. McCabe, James T. Hayden, Pieter Wesseling, Ingrid Øra, Monica Nistér, Mariëtte E. G. Kranendonk, Bastiaan B. J. Tops, Michal Zapotocky, Josef Zamecnik, Alexandre Vasiljevic, Tanguy Fenouil, David Meyronet, Katja von Hoff, Ulrich Schüller, Hugues Loiseau, Dominique Figarella-Branger, Christof M. Kramm, Dominik Sturm, David Scheie, Tuomas Rauramaa, Jouni Pesola, Johannes Gojo, Christine Haberler, Sebastian Brandner, Tom Jacques, Alexandra Sexton Oates, Richard Saffery, Ewa Koscielniak, Suzanne J. Baker, Stephen Yip, Matija Snuderl, Nasir Ud Din, David Samuel, Kathrin Schramm, Mirjam Blattner-Johnson, Florian Selt, Jonas Ecker, Till Milde, Andreas von Deimling, Andrey Korshunov, Arie Perry, Stefan M. Pfister, Felix Sahm, David A. Solomon, David T. W. Jones
Publikováno v:
Acta Neuropathologica. 145:511-514
Autor:
Marie Morfouace, Peter Horak, Simon Kreutzfeldt, Aleksandra Stevovic, Teresa de Rojas, Evgeniya Denisova, Barbara Hutter, Francisco Bautista, Júlio Oliveira, Anne-Sophie Defachelles, Jeff White, Bernd Kasper, Matthias Preusser, Vassilis Golfinopoulos, Stefan Pfister, Winette Van der Graaf, Eva Wardelmann, Patrick Shenjere, Stefan Fröhling, Martin G. McCabe
Publikováno v:
European Journal of Cancer, 178, 216-226. Elsevier Ltd.
Background: Adolescent and young adult (AYA) patients with cancer are poorly recruited to molecularly targeted trials and have not witnessed the advances in cancer treatment and survival seen in other age groups. We report here a pan-European proof-o
Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23
Autor:
Peter Hau, Didier Frappaz, Elizabeth Hovey, Martin G. McCabe, Kristian W. Pajtler, Benedikt Wiestler, Clemens Seidel, Stephanie E. Combs, Linda Dirven, Martin Klein, Antoinette Anazodo, Elke Hattingen, Silvia Hofer, Stefan M. Pfister, Claus Zimmer, Rolf-Dieter Kortmann, Marie-Pierre Sunyach, Ronan Tanguy, Rachel Effeney, Andreas von Deimling, Felix Sahm, Stefan Rutkowski, Anna S. Berghoff, Enrico Franceschi, Estela Pineda, Dagmar Beier, Ellen Peeters, Thierry Gorlia, Maureen Vanlancker, Jacoline E. C. Bromberg, Julien Gautier, David S. Ziegler, Matthias Preusser, Wolfgang Wick, Michael Weller
Publikováno v:
Cancers, Vol 13, Iss 14, p 3451 (2021)
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate prognosis. Standard treatment consists of maximal resection plus radio-chemotherapy. Treatment toxicity is high and produces disabling long-term side
Externí odkaz:
https://doaj.org/article/4a64cfee52e14099b8d93320a276b70b
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 22, p 8723 (2020)
Extracellular vesicles (EVs) are heterogeneous in size (30 nm–10 µm), content (lipid, RNA, DNA, protein), and potential function(s). Many isolation techniques routinely discard the large EVs at the early stages of small EV or exosome isolation pro
Externí odkaz:
https://doaj.org/article/5faa07189e5b435d92adf92e59508cd7
Autor:
Olga Husson, Martin G. McCabe, Vivian W G Burgers, Martin J. van den Bent, Daniël J. van der Meer, Anita W. Rijneveld, Winette T. A. van der Graaf
Publikováno v:
JNCCN Journal of the National Comprehensive Cancer Network, 19(3), 240-246. Cold Spring Publishing LLC
Burgers, V W G, van der Graaf, W T A, van der Meer, D J, McCabe, M G, Rijneveld, A W, van den Bent, M J & Husson, O 2021, ' Adolescents and Young Adults Living With an Uncertain or Poor Cancer Prognosis : The "New" Lost Tribe ', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 19, no. 3, pp. 240-246 . https://doi.org/10.6004/jnccn.2020.7696
Burgers, V W G, van der Graaf, W T A, van der Meer, D J, McCabe, M G, Rijneveld, A W, van den Bent, M J & Husson, O 2021, ' Adolescents and Young Adults Living With an Uncertain or Poor Cancer Prognosis : The "New" Lost Tribe ', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 19, no. 3, pp. 240-246 . https://doi.org/10.6004/jnccn.2020.7696
Historically, adolescent and young adult (AYA) patients with cancer, diagnosed for the first time at age 15 through 39 years, have often been identified as a “lost tribe” without a medical “home”; neither pediatric nor adult oncology services
Autor:
Richard Grundy, Helen Curley, Charles A. Stiller, Pamela Kearns, Jean-Baptiste Cazier, Csilla Várnai, Richard G. Feltbower, Ashley Gamble, Martin G. McCabe, Adam Glaser, Roland Arnold, Lennard Y W Lee, Gerard C Millen, Robert S. Phillips
Publikováno v:
British Journal of Cancer
Millen, G C, Arnold, R, Cazier, J-B, Curley, H, Feltbower, R G, Gamble, A, Glaser, A W, Grundy, R G, Lee, L Y W, McCabe, M G, Phillips, R S, Stiller, C A, Várnai, C & Kearns, P R 2021, ' Severity of COVID-19 in children with cancer : Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project ', British Journal of Cancer, vol. 124, no. 4, pp. 754-759 . https://doi.org/10.1038/s41416-020-01181-0
Millen, G C, Arnold, R, Cazier, J-B, Curley, H, Feltbower, R G, Gamble, A, Glaser, A W, Grundy, R G, Lee, L Y W, McCabe, M G, Phillips, R S, Stiller, C A, Várnai, C & Kearns, P R 2021, ' Severity of COVID-19 in children with cancer : Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project ', British Journal of Cancer, vol. 124, no. 4, pp. 754-759 . https://doi.org/10.1038/s41416-020-01181-0
Background Children with cancer are frequently immunocompromised. While children are generally thought to be at less risk of severe SARS-CoV-2 infection than adults, comprehensive population-based evidence for the risk in children with cancer is unav
Autor:
Roland Arnold, Charles A. Stiller, Lennard Y. W. Lee, Martin G. McCabe, Laura Kirton, Helen Curley, Jean-Baptiste Cazier, Richard G. Feltbower, Pamela Kearns, Csilla Várnai, Richard Grundy, Claire Palles, Ashley Gamble, Bob Phillips, Gerard C Millen, Adam Glaser
Publikováno v:
Archives of Disease in Childhood
Millen, G C, Arnold, R, Cazier, J-B, Curley, H, Feltbower, R, Gamble, A, Glaser, A, Grundy, R G, Kirton, L, Lee, L Y W, McCabe, M G, Palles, C, Phillips, B, Stiller, C A, Varnai, C & Kearns, P 2022, ' COVID-19 in children with haematological malignancies ', Archives of Disease in Childhood, vol. 107, no. 2, pp. 186-188 . https://doi.org/10.1136/archdischild-2021-322062
Millen, G C, Arnold, R, Cazier, J-B, Curley, H, Feltbower, R, Gamble, A, Glaser, A, Grundy, R G, Kirton, L, Lee, L Y W, McCabe, M G, Palles, C, Phillips, B, Stiller, C A, Varnai, C & Kearns, P 2022, ' COVID-19 in children with haematological malignancies ', Archives of Disease in Childhood, vol. 107, no. 2, pp. 186-188 . https://doi.org/10.1136/archdischild-2021-322062
Background Children with cancer are not at increased risk of severe SARS-CoV-2 infection; however, adults with haematological malignancies have increased risk of severe infections compared with non-haematological malignancies. Methods We compared pat
Autor:
Adam Glaser, Lesley Smith, Päivi M. Lähteenmäki, Charles A. Stiller, Jeanette Falck Winther, Martin G. McCabe, Robert A. Phillips, Joanne F. Aitken, Kathy Pritchard-Jones, Richard G. Feltbower, Eva Steliarova-Foucher, Ryan Woods, Tom Børge Johannesen, Lisa Lyngsie Hjalgrim
Publikováno v:
Smith, L, Stiller, C A, Aitken, J F, Hjalgrim, L L, Johannesen, T, Lahteenmaki, P, McCabe, M G, Phillips, R, Pritchard-Jones, K, Steliarova-Foucher, E, Winther, J F, Woods, R R, Glaser, A W & Feltbower, R G 2022, ' International variation in childhood cancer mortality rates from 2001 to 2015 : Comparison of trends in the International Cancer Benchmarking Partnership countries ', International Journal of Cancer, vol. 150, no. 1, pp. 28-37 . https://doi.org/10.1002/ijc.33774
Despite improved survival rates, cancer remains one of the most common causes of childhood death. The International Cancer Benchmarking Partnership (ICBP) showed variation in cancer survival for adults. We aimed to assess and compare trends over time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be8e7792f44d959b9e6b7e4eba7540fd
https://pure.au.dk/portal/da/publications/international-variation-in-childhood-cancer-mortality-rates-from-2001-to-2015(031c2297-4669-42db-b92f-4b6d517221a3).html
https://pure.au.dk/portal/da/publications/international-variation-in-childhood-cancer-mortality-rates-from-2001-to-2015(031c2297-4669-42db-b92f-4b6d517221a3).html
Autor:
Helen Parker, Alina Pandele, Gabriella Forte, Alan J. Dickson, Jessica T. Taylor, Kaye J. Williams, Shaun Wood, Catherine McBain, Martin G. McCabe, Erica Nathan, Stuart M. Ellison, Egor Zindy, Konstantina Karabatsou, Brian W. Bigger, Mark Elvin
Publikováno v:
Neuro-Oncology
Taylor, J T, Ellison, S, Pandele, A, Wood, S, Nathan, E, Forte, G, Parker, H, Zindy, E, Elvin, M, Dickson, A, Williams, K J, Karabatsou, K, McCabe, M, McBain, C & Bigger, B W 2020, ' Actinomycin D Downregulates Sox2 and Improves Survival in Preclinical Models of Recurrent Glioblastoma ', Neuro-Oncology, vol. 22, no. 9, pp. 1289-1301 . https://doi.org/10.1093/neuonc/noaa051
Neuro-oncology, 22 (9
Taylor, J T, Ellison, S, Pandele, A, Wood, S, Nathan, E, Forte, G, Parker, H, Zindy, E, Elvin, M, Dickson, A, Williams, K J, Karabatsou, K, McCabe, M, McBain, C & Bigger, B W 2020, ' Actinomycin D Downregulates Sox2 and Improves Survival in Preclinical Models of Recurrent Glioblastoma ', Neuro-Oncology, vol. 22, no. 9, pp. 1289-1301 . https://doi.org/10.1093/neuonc/noaa051
Neuro-oncology, 22 (9
Background Glioblastoma (GBM) has been extensively researched over the last few decades, yet despite aggressive multimodal treatment, recurrence is inevitable and second-line treatment options are limited. Here, we demonstrate how high-throughput scr